The average price of new drugs has risen by 35% in 2023 compared to the previous year in the US, with gene therapies becoming the most expensive treatments due to their curative potential and rarity of the conditions they treat. Among these are Orchard Therapeutics’ Lenmeldy for metachromatic leukodystrophy ($4.25 million), uniQure’s Hemgenix for hemophilia B ($3.5 million), Sarepta Therapeutics’ Elevidys for Duchenne muscular dystrophy ($3.2 million), and Vertex Pharmaceuticals’ Casgevy for sickle cell disease and beta-thalassemia ($2.2 million).
New GitHub Actions Attack Chain Uses Fake CI Updates to Exfiltrate Secrets and Tokens
A new attack campaign is actively targeting open-source repositories on GitHub by carefully disguising malicious code as completely routine CI build configuration updates. The campaign,
